Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
The Primary Care Companion for CNS Disorders|March 24, 2018
Galantamine-Memantine Combination for Cognitive Impairments Due to Electroconvulsive Therapy, Traumatic Brain Injury, and Neurologic and Psychiatric Disorders: Kynurenic Acid and Mismatch Negativity Target EngagementMaju Mathew KoolaIndian Journal of Psychological Medicine|April 27, 2016
Cytokines in Schizophrenia: Hope or Hype?Maju Mathew KoolaIndian Journal of Psychological Medicine|March 25, 2016
Methodological Issues in Cytokine Measurement in SchizophreniaMaju Mathew KoolaSchizophrenia Research. Cognition|April 13, 2016
Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantineMaju Mathew KoolaMolecular Neuropsychiatry|November 7, 2018
Attenuated Mismatch Negativity in Attenuated Psychosis Syndrome Predicts Psychosis: Can Galantamine-Memantine Combination Prevent Psychosis?Maju Mathew KoolaAsian Journal of Psychiatry|February 19, 2019
Antipsychotic-minocycline-acetylcysteine combination for positive, cognitive, and negative symptoms of schizophreniaMaju Mathew KoolaHuman Psychopharmacology|September 23, 2020
Alpha7 nicotinic-N-methyl-D-aspartate hypothesis in the treatment of schizophrenia and beyondMaju Mathew KoolaMolecular Neuropsychiatry|January 16, 2019
Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of SchizophreniaMaju Mathew KoolaPsychiatry Research|August 24, 2020
Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyondMaju Mathew KoolaAsian Journal of Psychiatry|December 21, 2018
Barriers faced by immigrant families of children with autism: A program to address the challengesBiruntha Sritharan, Maju Mathew KoolaPageof 7